David A. Rosa - Apr 21, 2023 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Role: CEO and President, Director
Signature: /s/ Stephanie Swan, by Power of Attorney
Stock symbol: NMTC
Transactions as of: Apr 21, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/25/2023, 02:58 PM
Previous filing: Apr 4, 2023
Next filing: May 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NMTC	Common Stock	Award	$0	+91.5K	+19.95%	$0.00	550K	Apr 21, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NMTC	Option to Purchase Common Stock	Award	$0	+91.5K		$0.00	91.5K	Apr 21, 2023	Common Stock	91.5K	$1.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments on the last day of each quarter over the next 8 quarters, subject to continued service on such vesting date.
F2	25% will vest on April 21, 2024 and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2024.